Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5672_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
10 Мб
Скачать
☆
14
Metals in Medicine, Volume 2
         

         
applied. Liu et al. developed gold-based nanoclusters (Au
25
(Capt)
18
)

concurrent photodynamic and photothermal treatments using 808 nm NIR

68

25
(Capt)
18
           
a high temperature (up to 60°     


FIGURE 1.5 
25
(Capt)
18

Au
25
(Capt)
18


nm, 2 W cm
2


mL1 Au
25
(Capt)
18

cm
2

1
O
2
by Au
25
(Capt)
18



2

1
O
2
by Au
25
(Capt)
18


Source
https://t.me/med1917
Gold-based Nanoparticles and Their Applications in Cancer Therapy
15
pH-responsive drug release properties (PEG-AuNRs-MPH


     
69
to



       

releasing the ALA and DOX into the cytoplasm. Upon exposure to NIR
   
the tumor (60°      
      

cell death count, in addition to no systematic toxicity observed (Figure 1.6).
FIGURE 1.6         


-PEG, and

2

2
), and 635 and 808

         



Source
https://t.me/med1917
16
Metals in Medicine, Volume 2


         

in internal organs (liver, lungs, kidney),
70,71

72
(Figure 1.7).

-


71
Despite these
advantages, this strategy is prone to several limitations including invasive
-



i.e., both normal and tumorous tissues around the electrodes experience
thermal injury.
73
FIGURE 1.7 

Source
          
accumulate in the tumor, they are used as a target molecule to increase the
        

74


    
intracellular structures.
73

75

https://t.me/med1917
Gold-based Nanoparticles and Their Applications in Cancer Therapy
17



cell lines.
76



           
       
      
77
Another distinctive

        
         

      

78
When combined

 

apoptosis).
79
1.3 SYNTHESIS OF AuNPs
      
three categories: Physical, Chemical, and Biological (including Green and
plant-based).





39
        

   

80

       
       

81
https://t.me/med1917
18
Metals in Medicine, Volume 2


       
82



83
       

anticancer therapy applications including photothermal and photodynamic


       
     
their diameter or less).
1
       

84


controlled synthesis methods are
        
-
     

85
(Figure 1.8a).

        

variables.

         

        

86,87


6
H
5
Na
3
O
7
) to the chloroauric acid (HAuCl
4
)
-

86

       
 
88
   

          

https://t.me/med1917
Gold-based Nanoparticles and Their Applications in Cancer Therapy
19
TABLE 1.2 

.
Concentration (conc.) of
hydrogen tetrachloro aurate (M)
Conc. of
CTAB (M)
Conc. of
2,7-DHN (M)
Conc. of sodium
hydroxide (M)
Microwave
time (s)
Average size
(nm)
Shape distribution
3.17 e-04 6.34 e-03 3.17 e-03 1.15 e-02 90 25 ± 2 
4.21 e-04 8.42 e-03 1.03 e-03 1.05 e-02 90 50–120 

4.71 e-04 7.54 e-03 1.88 e-03 9.43 e-03 90 Aspect ratio
12 (530–720)

6.94 e-04 8.68 e-02 6.07 e-04 1.73 e-04 90 65 ± 10 

https://t.me/med1917
20
Metals in Medicine, Volume 2

nanoparticles.
89
    



aggregation. As a result, the incident particle occurs due to this aggrega-
tion,
89


FIGURE 1.8     

        
        
  
90
      

Source

          
      
https://t.me/med1917
Gold-based Nanoparticles and Their Applications in Cancer Therapy
21

      

ions that
are converted into Au
0
atoms,
91
     
       
   
92
and poly(2-
aminothiophenol),
93
magnesium oxide
94
    

• 
95
and it is



agent is sodium borohydride (NaBH
4



91


         
    
this method.
96
•        
         
a reducing element, the sodium citrate is a capping agent that




      

• 

4

4
agent


            
      
4
   
months, and NaBH
4
         

nm to 5 nm.
99


https://t.me/med1917
22
Metals in Medicine, Volume 2
TABLE 1.3 
Advantages and Disadvantages.

Method Advantages Disadvantages References

Frens

monodispersed AuNPs

nm

aggregation,

implementation in medical
and biological research.
97,98
Brust-


AuNPs,

nm,

stability and high thermal
properties,
Highly reproducible.

particles larger than 6 nm.

agent to produce AuNPs.
95
Martin 




larger than 5 nm

agents are required to

99

         

-


     

in several studies to produce extracellular and intracellular AuNPs.
91


     
and physical characteristics.
Biomolecules: including nucleic acids, amino acids, carbohydrates, and

reducing the Au

ions to Au
0


https://t.me/med1917
Gold-based Nanoparticles and Their Applications in Cancer Therapy
23




     -


       
based on processing Au


       -

TABLE 1.4    
Morphological Characteristics.

Plant-based extracts UV visual. SEM/DL/TEM FTIR spectroscopy EDS
 560–800
nm
50–350 nm, hexagonal,
truncated triangular,
and triangular.
Alcoholic and
carbonyl groups

Dried Anacardium
occidentale leaves
260–530
nm
6–17 nm Proteins, polyphe-
nols, and aromatic
amines
-
Potamogeton
pectinatus
543 nm 8.5 nm O-H, COOH, C-C,
C-H, C-N and amide
C-O, N-H


and Si
Apiin compound
(henna leaves)
550–950
nm
21 nm, quasi-spherical
and triangular.

process involves
carbonyl groups.
–
Camellia sinensis
leaves
550 nm 30–40 nm – –
Chenopodium album
leaves
540 nm 10–30 nm 
process involves
carboxyl groups.



Cinnamomum
camphora leaves
520–570
nm
10–40 nm, spherical
and triangular particles
Heterocyclic
compounds


Cymbopogon sp.
leaves
525 nm 200–500 nm, hexagonal
and triangular.
- -
Memecylon edule
leaves
530–555
nm
20–50 nm, hexagonal
and triangular.
Carbonyl stretching 
Mentha piperita
(peppermint)
540 nm 5–150 nm, spherical
particles
N-H group 
Si.
https://t.me/med1917